Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL1883384

CCn1/c(=N\N=c2\sc3cc(S(=O)(=O)O)ccc3n2CC)sc2cc(S(=O)(=O)O)ccc21.N

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
NPSR1 Q6W5P4 8/20 0.42
ALDH1A1 P00352 7/20 0.42
TSHR P16473 3/20 0.42
PKM P14618 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 6/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
MAPK1 P28482 1/20 0.38
HPGD P15428 4/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL2319900 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL668709 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL306103 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL21840 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL21839 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL432548 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL13458992 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL63297 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL14599149 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL7915441 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9778257-B2 Autoantibody detection method, method for testing possibility of autoimmune disease contraction, autoantibody detection reagent, and autoimmune disease test reagent OSAKA UNIVERSITY (JP) 2017-10-03 US disclosed
US-20170176432-A1 AUTOANTIBODY DETECTION METHOD, METHOD FOR TESTING POSSIBILITY OF AUTOIMMUNE DISEASE CONTRACTION, AUTOANTIBODY DETECTION REAGENT, AND AUTOIMMUNE DISEASE TEST REAGENT OSAKA UNIVERSITY (JP) 2017-06-22 US disclosed
EP-2251425-B1 Process for producing protein A-like protein with use of Brevibacillus genus bacterium KANEKA CORP (JP) 2016-04-20 EP disclosed
US-7939077-B2 DNA sequences that code antibodies or fragments; genetic vectors and host cells transformed by the vector, used for diagnosis and prophylaxis of cancer KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-05-10 US disclosed
EP-1676862-B1 RECOMBINANT ANTIBODY AGAINST HUMAN INSULIN-LIKE GROWTH FACTOR KYOWA HAKKO KIRIN CO LTD (JP) 2010-12-22 EP disclosed
EP-2251425-A1 Process for producing protein A-like protein with use of Brevibacillus genus bacterium Kaneka Corporation (JP) 2010-11-17 EP disclosed
US-7763246-B2 Platelet-derived growth factor receptor specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-07-27 US disclosed
EP-1505075-B1 ANTIBODY TO HUMAN INSULIN-LIKE GROWTH FACTOR KYOWA HAKKO KIRIN CO LTD (JP) 2009-10-07 EP disclosed
US-7498415-B2 Recombinant antibody against human insulin-like growth factor KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-03-03 US disclosed
US-7438911-B2 Antibody against human insulin-like growth factor KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-10-21 US disclosed
US-7241568-B2 Anti-fibroblast growth factor-8 monoclonal antibody KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-10 US disclosed
EP-1767640-A1 PROCESS FOR PRODUCING PROTEIN A-LIKE PROTEIN WITH USE OF BREVIBACILLUS GENUS BACATERIUM Kaneka Corporation (JP) 2007-03-28 EP disclosed
US-20060240015-A1 Recombinant antibody against human insulin-like growth factor KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-10-26 US disclosed
US-20060165695-A1 Antibody against human insulin-like growth factor KYOWA HAKKO KIRIN CO., LTD. (JP) 2006-07-27 US disclosed
EP-1676862-A1 RECOMBINANT ANTIBODY AGAINST HUMAN INSULIN-LIKE GROWTH FACTOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-07-05 EP disclosed
EP-1505075-A1 ANTIBODY TO HUMAN INSULIN-LIKE GROWTH FACTOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-02-09 EP disclosed
US-20040253234-A1 Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof KYOWA HAKKO KIRIN CO., LTD. (JP) 2004-12-16 US disclosed
EP-1422243-A1 HUMANIZED ANTIBODY AGAINST FIBROBLAST GROWTH FACTOR−8 AND FRAGMENT OF THE ANTIBODY Kyowa Hakko Kogyo Co., Ltd (JP) 2004-05-26 EP disclosed
US-20040091480-A1 Anti-fibroblast growth factor-8 monoclonal antibody KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-05-13 US disclosed
EP-1308509-A1 NOVEL PHYSIOLOGICALLY ACTIVE PEPTIDE AND USE THEREOF KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-05-07 EP disclosed